Universal Vision Valuation
| 3218 Stock | TWD 211.00 4.00 1.86% |
At this time, the company appears to be overvalued. Universal Vision Bio has a current Real Value of NT$154.8 per share. The regular price of the company is NT$211.0. Our model measures the value of Universal Vision Bio from inspecting the company fundamentals such as Shares Outstanding of 79.93 M, operating margin of 0.31 %, and Return On Equity of 0.34 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Universal Vision's price fluctuation is very steady at this time. Calculation of the real value of Universal Vision Bio is based on 3 months time horizon. Increasing Universal Vision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Universal stock is determined by what a typical buyer is willing to pay for full or partial control of Universal Vision Biotechnology. Since Universal Vision is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Universal Stock. However, Universal Vision's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 211.0 | Real 154.8 | Hype 215.0 | Naive 200.93 |
The intrinsic value of Universal Vision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Universal Vision's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Universal Vision Biotechnology helps investors to forecast how Universal stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Universal Vision more accurately as focusing exclusively on Universal Vision's fundamentals will not take into account other important factors: Universal Vision Total Value Analysis
Universal Vision Biotechnology is presently anticipated to have takeover price of 23.15 B with market capitalization of 26.06 B, debt of 10.33 M, and cash on hands of 1.06 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Universal Vision fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.15 B | 26.06 B | 10.33 M | 1.06 B |
Universal Vision Investor Information
About 48.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 9.88. Universal Vision Bio last dividend was issued on the 21st of April 2022. The entity had 1000:1060 split on the 25th of August 2023. Based on the analysis of Universal Vision's profitability, liquidity, and operating efficiency, Universal Vision Biotechnology is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Universal Vision Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Universal Vision has an asset utilization ratio of 70.19 percent. This indicates that the Company is making NT$0.7 for each dollar of assets. An increasing asset utilization means that Universal Vision Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Universal Vision Ownership Allocation
Universal Vision Bio shows a total of 79.93 Million outstanding shares. Universal Vision Bio maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Universal Vision Profitability Analysis
The company reported the revenue of 2.63 B. Net Income was 595.43 M with profit before overhead, payroll, taxes, and interest of 1.64 B.About Universal Vision Valuation
Our relative valuation model uses a comparative analysis of Universal Vision. We calculate exposure to Universal Vision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Universal Vision's related companies.Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan. UNIVERSAL VISION is traded on Taiwan OTC Exchange in Taiwan.
8 Steps to conduct Universal Vision's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Universal Vision's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Universal Vision's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Universal Vision's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Universal Vision's revenue streams: Identify Universal Vision's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Universal Vision's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Universal Vision's growth potential: Evaluate Universal Vision's management, business model, and growth potential.
- Determine Universal Vision's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Universal Vision's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Universal Stock Analysis
When running Universal Vision's price analysis, check to measure Universal Vision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Vision is operating at the current time. Most of Universal Vision's value examination focuses on studying past and present price action to predict the probability of Universal Vision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Vision's price. Additionally, you may evaluate how the addition of Universal Vision to your portfolios can decrease your overall portfolio volatility.